Li Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li Zhong has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Bo Ning
Department of Gastroenterology, 2nd Affiliated Hospital of Chongqing Medical University
1 shared publicationCan Cai
Department of Gastroenterology, 2nd Affiliated Hospital of Chongqing Medical University
1 shared publicationChang Liu
Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publicationKeshu Xu
Department of Gastroenterology, Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Wuhan, China
1 shared publicationLiang Deng
Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University
1 shared publication- Liang Deng
Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- Open Access
Liver X Receptor β Controls Hepatic Stellate Cell Activation via Hedgehog Signaling
Liver X receptors (LXR) α and β serve important roles in cholesterol homeostasis, anti-inflammatory processes and the activation of hepatic stellate cells (HSCs). However, the development of therapies for liver fibrosis based on LXR agonists have been hampered due to side-effects such as liver steatosis. In this study, we demonstrated that HSCs expressed high levels of LXRβ, but not LXRα, and that overexpression of LXRβ suppressed fibrosis and HSC activation in a carbon tetrachloride (CCl 4 )-induced fibrosis mouse model, without resulting in liver steatosis. Furthermore, Hedgehog (Hh)-regulated proteins, markedly increased in the CCl 4 -affected liver and mainly expressed in activated HSCs, were repressed under conditions of LXRβ overexpression. In addition, LXRβ knockout led to activation of Hh signaling and triggering of HSC activation, while overexpression of LXRβ led to the inhibition of the Hh pathway and suppression of HSC activation. These results suggest that LXRβ suppresses the activation mechanism of HSCs by inhibiting Hh signaling. In conclusion, LXRβ, by restoring the differentiation of HSCs, may be a promising therapeutic target for liver fibrosis without the adverse side-effects of LXRα activation.
Open AccessLiver X Receptor β Controls Hepatic Stellate Cell Activation via Hedgehog Signaling
Liver X receptors (LXR) α and β serve important roles in cholesterol homeostasis, anti-inflammatory processes and the activation of hepatic stellate cells (HSCs). However, the development of therapies for liver fibrosis based on LXR agonists have been hampered due to side-effects such as liver steatosis. In this study, we demonstrated that HSCs expressed high levels of LXRβ, but not LXRα, and that overexpression of LXRβ suppressed fibrosis and HSC activation in a carbon tetrachloride (CCl 4 )-induced fibrosis mouse model, without resulting in liver steatosis. Furthermore, Hedgehog (Hh)-regulated proteins, markedly increased in the CCl 4 -affected liver and mainly expressed in activated HSCs, were repressed under conditions of LXRβ overexpression. In addition, LXRβ knockout led to activation of Hh signaling and triggering of HSC activation, while overexpression of LXRβ led to the inhibition of the Hh pathway and suppression of HSC activation. These results suggest that LXRβ suppresses the activation mechanism of HSCs by inhibiting Hh signaling. In conclusion, LXRβ, by restoring the differentiation of HSCs, may be a promising therapeutic target for liver fibrosis without the adverse side-effects of LXRα activation.
- 11 February 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (7) , 11761-11774
Cell‐specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP‐1 in high‐fat diet‐induced mice NAFLD
Objective: We have demonstrated runt‐related transcription factor 2 (Runx2) plays important role in atherosclerosis. It has been indicated that atherosclerosis shares the similar histopathology with nonalcoholic steatohepatitis (NASH), a progressive stage of nonalcoholic fatty liver disease (NAFLD), on macrophages infiltration. However, the function of Runx2 in NAFLD is completely unknown. Here, we investigated the underlying mechanism of Runx2 triggering macrophages infiltration in the development of NAFLD.Methods: Mice were fed with high‐fat diet (HFD) for a long time. Histopathologic features, macrophages infiltration, expression of monocyte chemotactic protein 1 (MCP‐1), and Runx2 were, respectively, analyzed in vivo. Lentivirus or short interfering RNA were transfected in murine hepatic stellate cells (HSCs) and the transwell assay was performed to verify the contribution of Runx2 for macrophages migration in vitro.Results: Long‐term treatment with HFD induced the progression of NAFLD, and NASH was initiated from 8 months on diet. HFD increased the expression of F4/80 upon HFD feeding, indicated HFD promotes hepatic infiltration of macrophages in NAFLD. In addition, HFD upregulated the expression of MCP‐1 and Runx2 during NAFLD development. Unexpectedly, Runx2 upregulation is cell‐type depended in NAFLD, and only abundantly elevated in activated HSCs. Furthermore, we found that Runx2 could increase or decrease the expression of MCP‐1 in HSCs, and regulate macrophages migration by influencing MCP‐1 production in vitro.Conclusions: Our results give evidence that the upregulation of Runx2 specific in activated HSCs promotes hepatic infiltration of macrophages by increasing MCP‐1 expression in NAFLD, which reveals a novel mechanism and provides a cell‐specific therapeutic target for NAFLD.
- 11 February 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (7) , 11761-11774
Cell‐specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP‐1 in high‐fat diet‐induced mice NAFLD
Objective: We have demonstrated runt‐related transcription factor 2 (Runx2) plays important role in atherosclerosis. It has been indicated that atherosclerosis shares the similar histopathology with nonalcoholic steatohepatitis (NASH), a progressive stage of nonalcoholic fatty liver disease (NAFLD), on macrophages infiltration. However, the function of Runx2 in NAFLD is completely unknown. Here, we investigated the underlying mechanism of Runx2 triggering macrophages infiltration in the development of NAFLD.Methods: Mice were fed with high‐fat diet (HFD) for a long time. Histopathologic features, macrophages infiltration, expression of monocyte chemotactic protein 1 (MCP‐1), and Runx2 were, respectively, analyzed in vivo. Lentivirus or short interfering RNA were transfected in murine hepatic stellate cells (HSCs) and the transwell assay was performed to verify the contribution of Runx2 for macrophages migration in vitro.Results: Long‐term treatment with HFD induced the progression of NAFLD, and NASH was initiated from 8 months on diet. HFD increased the expression of F4/80 upon HFD feeding, indicated HFD promotes hepatic infiltration of macrophages in NAFLD. In addition, HFD upregulated the expression of MCP‐1 and Runx2 during NAFLD development. Unexpectedly, Runx2 upregulation is cell‐type depended in NAFLD, and only abundantly elevated in activated HSCs. Furthermore, we found that Runx2 could increase or decrease the expression of MCP‐1 in HSCs, and regulate macrophages migration by influencing MCP‐1 production in vitro.Conclusions: Our results give evidence that the upregulation of Runx2 specific in activated HSCs promotes hepatic infiltration of macrophages by increasing MCP‐1 expression in NAFLD, which reveals a novel mechanism and provides a cell‐specific therapeutic target for NAFLD.